Help | RSS Feed



CSL Limited (OTCMKT:CSLLY) Seasonal Chart

CSLLY Relative to the S&P 500
CSLLY Relative to the S&P 500

CSLLY Relative to the Sector
CSLLY Relative to the Sector

Monthly Seasonal CSL Limited (OTCMKT:CSLLY)

Seasonal Chart Analysis

Analysis of the CSL Limited (OTCMKT:CSLLY) seasonal charts above shows that a Buy Date of November 26 and a Sell Date of April 9 has resulted in a geometric average return of 8.19% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 11 of those periods. This is an excellent rate of success and the return slightly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 0.23% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

CSL is the one of largest global biotech companies. Products are focused on two key areas ? protein science therapies such as plasma-derived immunoglobulins for the treatment of immune deficiencies and neurological conditions, in its CSL Behring division, and influenza vaccines, in its Seqirus division. CSL has a strong research and development track record. The portfolio and pipeline include non-plasma products as the company broadens its biotech scope. Originally formed in Australia as a commonwealth-owned entity, CSL now earns half its revenue in North America and a quarter in Europe.

To download CSLLY seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore